News

Search Articles

1336 - 1350 of 1367 Results Clear All

Article June 14, 2010

Gladstone and Institute for Systems Biology Collaborate to Discover New Genes Associated With the Onset of Huntington’s Disease

SAN FRANCISCO, CA—June 15, 2010—The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets

Huntington’s Disease

April 19, 2010

Gladstone’s Deepak Srivastava Elected to the American Academy of Arts and Sciences

SAN FRANCISCO, CA—April 20, 2010—Deepak Srivastava, MD, director of the Gladstone Institute of Cardiovascular Disease and Professor of Pediatrics and Biochemistry at UCSF, has been elected to the American Academy of Arts and Sciences. Srivastava joins former Gladstone president Robert W.

March 2, 2010

Gladstone Scientists Identify Key Protein in Energy Regulation

SAN FRANCISCO—March 3, 2010—With obesity and obesity-related diseases epidemic in the developed world, a clear understanding of how metabolism is regulated is crucial. One of the key metabolic pathways involves the oxidation of fat.

Article February 17, 2010

Gladstone’s Lennart Mucke Wins Potamkin Prize for Identifying New Avenues in Alzheimer’s Research

SAN FRANCISCO, CA—February 18, 2010—Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.

Awards Alzheimer’s Disease

Article February 9, 2010

Gladstone’s Robert Mahley to Receive Research!America Advocacy Award

WASHINGTON—February 10, 2010—Robert W. Mahley, MD, PhD, president of The J. David Gladstone Institutes, will receive Research!America's 2010 Builders of Science Award.

Awards

February 7, 2010

Gladstone Institutes Completes its First Fundraising Campaign

SAN FRANCISCO, CA—February 8, 2010—The J. David Gladstone Institutes has announced the completion of its first fundraising campaign. The independent biomedical research organization, located at Mission Bay, said it had exceeded its goal of $35 million, despite tough economic times.

February 2, 2010

Gladstone Scientists Identify Target That May Reduce Complications of Obesity

SAN FRANCISCO, CA—February 3, 2010—Although obesity is a risk factor for diabetes and coronary heart disease worldwide, only some obese individuals go on to develop these metabolic complications, while others are relatively protected.

January 25, 2010

Gladstone’s Yamanaka Receives March of Dimes Prize in Developmental Biology

SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) was awarded the 2010 March of Dimes Prize in Developmental Biology.

January 12, 2010

Gladstone Scientists Identify Role of Key Protein in ALS and Frontotemporal Dementia

SAN FRANCISCO, CA—January 13, 2010—Scientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases.

January 3, 2010

Gladstone Scientists Identify Agent That May Inhibit HIV Infectivity

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.

Greene Lab HIV/AIDS

Article December 2, 2009

Gladstone Scientists Identify Strategies To Protect New Brain Cells Against Alzheimer’s Disease

SAN FRANCISCO, CA—Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally?

Alzheimer’s Disease Gan Lab Huang Lab

November 8, 2009

Gladstone Taps Former UCSF Advancement Official for Strategic Planning Role

SAN FRANCISCO, CA—November 9, 2009—The Gladstone Institutes today announced that it has hired Bruce Spaulding, who recently retired as UCSF'S senior vice chancellor of advancement and planning as its new chief of strategic planning, effective December 14th.

October 31, 2009

Gladstone and Stanford In Collaboration to Develop Induced Pluripotent Stem (IPS) Cells for Cardiac Therapies

SAN FRANCISCO, CA—November 1, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine t

October 27, 2009

Gladstone Repeats In Top 10 Best Places to Work In Academia

SAN FRANCISCO, CA—October 28, 2009—For the fifth year in a row, The J. David Gladstone Institutes has placed among the top 10 among the Best Places to Work in Academia.

October 27, 2009

Gladstone Scientists Receive $10 Million to Identify Genetic Cause of Congenital Heart Disease

SAN FRANCISCO, CA—October 28, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) will receive $10 million over the next 6 years to find the genetic causes of congenital heart disease.

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media

Are You a Journalist Looking to Write about Gladstone?

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!